Skip to main content

CBRE (CBRE): Buy, Sell, or Hold Post Q2 Earnings?

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CBRE Cover Image

CBRE has been treading water for the past six months, recording a small return of 2.6% while holding steady at $136.36. The stock also fell short of the S&P 500’s 18.4% gain during that period.

Is now the time to buy CBRE, or should you be careful about including it in your portfolio? Check out our in-depth research report to see what our analysts have to say, it’s free.

Why Do We Think CBRE Will Underperform?

We’re cautious about CBRE. Here are three reasons you should be careful with CBRE, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term performance is an indicator of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, CBRE grew its sales at a 11.8% annual rate. Although this growth is acceptable on an absolute basis, it fell short of our standards for the consumer discretionary sector, which enjoys a number of secular tailwinds.

CBRE Quarterly Revenue

2. Mediocre Free Cash Flow Margin Limits Reinvestment Potential

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

CBRE has shown poor cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 2.5%, below what we’d expect for a consumer discretionary business.

CBRE Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

A company’s ROIC, or return on invested capital, shows how much operating profit it makes compared to the money it has raised (debt and equity).

Unfortunately, CBRE’s ROIC averaged 1.9 percentage point decreases each year over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

CBRE Trailing 12-Month Return On Invested Capital

Final Judgment

CBRE doesn’t pass our quality test. With its shares trailing the market in recent months, the stock trades at 17.5× forward P/E (or $136.36 per share). This valuation tells us a lot of optimism is priced in - you can find more timely opportunities elsewhere. We’d recommend looking at the most dominant software business in the world.

Stocks We Would Buy Instead of CBRE

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.91
-1.36 (-0.55%)
AAPL  337.87
+0.85 (0.25%)
AMD  619.29
+4.68 (0.76%)
BAC  56.03
+0.03 (0.05%)
GOOG  336.94
+1.96 (0.59%)
META  768.30
+24.20 (3.25%)
MSFT  495.35
-5.24 (-1.05%)
NVDA  223.38
-2.12 (-0.94%)
ORCL  138.59
-5.97 (-4.13%)
TSLA  380.42
+0.30 (0.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.